Reviewed by Dustin Brown, MS, FACHE. Last reviewed July 2026.
Medicaid covers diabetes supplies in every state: meters, test strips, lancets, insulin, syringes, pens, pumps, and now continuous glucose monitors in almost every state. CGM coverage has expanded dramatically and many states have dropped the old requirement of three or more daily insulin injections. Copays are nominal, often zero. The friction is not whether supplies are covered but quantity limits, preferred product lists, and prior authorisation, all of which are appealable. For children under 21 the rules are stronger than most people realise, and a denial can be challenged on different grounds entirely. Here is what is covered and how to fix a denial.
What Is Covered
Blood glucose meters, test strips, lancets and lancing devices, control solution, insulin, syringes and pen needles, glucagon including nasal forms, insulin pumps and pump supplies, continuous glucose monitors, and ketone strips.
One structural detail worth knowing early: your state delivers these either as a pharmacy benefit or a durable medical equipment benefit. This determines where you get them and, importantly, which appeal path applies if you are denied. Roughly 33 states now run CGMs through the pharmacy benefit, which generally means faster access at a retail pharmacy.
Diabetes self-management education and medical nutrition therapy are optional benefits, covered variably.
Continuous Glucose Monitors
This is where coverage has changed most, and where outdated information does the most harm.
Almost every state Medicaid programme now covers CGMs. A widely cited scan found 45 states plus DC with published fee-for-service coverage, and several of the remaining states have acted since. The accurate statement is that coverage is near-universal but criteria vary widely, rather than that all 50 states cover it identically.
Typical criteria: a diabetes diagnosis, type 1 or type 2; insulin use, where many states have moved from requiring three or more injections a day to accepting any insulin regimen; or documented problematic hypoglycaemia including hypoglycaemia unawareness, regardless of insulin use; prior fingerstick testing several times daily; regular visits with the prescriber; and documented training.
States are broadly aligning with Medicare’s expanded criteria, which now cover insulin-treated type 2 diabetes and non-insulin patients with a history of problematic hypoglycaemia. Professional guidelines recommend CGM for all insulin-treated adults.
If you were told years ago that you did not qualify, it is worth asking again. The criteria in many states have loosened considerably.
Quantity Limits on Test Strips
This is the most common source of frustration, and the limits follow a predictable structure.
| Situation | Typical allowance |
|---|---|
| Not using insulin | Around 1 strip per day |
| Using insulin | Around 3 to 10 strips per day |
| Using a CGM | Reduced allowance, for confirmatory testing only |
Actual limits vary by state. Some allow 250 strips per 30 days for a preferred product, others cap at 200 a month. Lancet limits generally mirror strip limits.
The CGM reduction catches people out, since starting a CGM can trigger an automatic cut to your strip allowance even though confirmatory testing is still needed.
Preferred Products and Prior Authorisation
Nearly every state maintains a preferred diabetic supply list. One or two meter and strip brands are preferred and need no prior authorisation, while everything else does. New enrollees are frequently required to switch meters.
Prior authorisation is standard for non-preferred strips or meters, any quantity above the standard limit, CGMs, insulin pumps, and non-preferred insulins.
A prior authorisation request works best when it states the diabetes type, the insulin regimen, the prescribed testing frequency, and specific clinical justification.
What You Pay
Medicaid enrollees typically pay nothing or a nominal copay, commonly $0 to $4 per prescription, subject to the overall cap of 5% of household income on cost sharing.
One thing to be clear about: the $35 monthly insulin cap applies to Medicare, not Medicaid. It came from the Inflation Reduction Act and covers Part D and insulin used in Part B pumps. Medicaid enrollees generally pay less than $35 anyway, so this is not a gap, but the two programmes are frequently confused.
How to Overturn a Denial
Denials on quantity limits and CGMs are frequently reversed. The process rewards knowing a few specifics.
Read the denial notice. It states the reason, the deadline, and the appeal route. The deadline matters more than anything else here.
If you are in a managed care plan, you must exhaust the plan’s internal appeal first, then request a State Fair Hearing. You have at least 120 days from the plan’s final decision to request that hearing. In fee-for-service Medicaid you go straight to a fair hearing, typically within 30 to 90 days.
Ask for benefits to continue during the appeal. If the decision reduces or ends something you already receive, requesting continued benefits within the notice deadline, usually 10 days, keeps supplies flowing while the appeal runs. This is not available for a first-time denial of something new.
Request an expedited appeal where delay risks serious harm, such as hypoglycaemia unawareness or risk of ketoacidosis. These are typically decided within 72 hours.
For a quantity limit, have the prescriber submit the prescribed testing frequency, documented hypoglycaemia episodes, recent A1c, glucose log data, and an explicit statement that the standard limit is medically insufficient.
If the patient is under 21, say EPSDT in writing. This is the strongest available argument. Under the EPSDT requirement, states must cover any medically necessary service for children, even one not covered for adults, and blanket limits do not lawfully apply. A CGM denial for a child should be challenged on those grounds specifically.
You can also escalate in parallel to your state Medicaid ombudsman, legal aid, or your state’s protection and advocacy agency.
If You Are Uninsured Rather Than on Medicaid
Check Medicaid eligibility first. Enrolment is open year-round with no annual window, so this is worth doing immediately.
Insulin has become considerably cheaper. All three major manufacturers now cap monthly costs at $35. Eli Lilly’s programme applies to insured and uninsured people with no income verification, Novo Nordisk offers the same plus free insulin through its patient assistance programme for households at or below 400% of the poverty level, and Sanofi extended its $35 cap to all US patients from January 2026.
Federally qualified health centres use income-based sliding scales and many operate discounted pharmacies with very low-cost insulin and supplies.
Store-brand supplies. Human insulin is available at some large retailers for around $25 a vial without a prescription, and cash-price meters and strips are among the cheapest options available.
In an emergency, most states have an urgent-need insulin law allowing a pharmacist to dispense a 30-day emergency supply. Ask for it by that name.
Medicaid Diabetes Supplies FAQs
Does Medicaid cover continuous glucose monitors?
In almost every state now, yes. Criteria vary, but many states have dropped the old requirement for three or more daily insulin injections and will cover CGMs for any insulin use or for documented problematic hypoglycaemia.
How many test strips will Medicaid cover?
Typically around one a day if you do not use insulin and three to ten a day if you do, varying by state. Starting a CGM usually reduces the strip allowance to confirmatory testing only.
What if I need more strips than the limit allows?
Your prescriber can request an override with the prescribed testing frequency, documented hypoglycaemia, A1c, and log data, stating that the standard limit is medically insufficient. Denials on quantity limits are frequently overturned.
What do diabetes supplies cost on Medicaid?
Nothing or a nominal copay, commonly $0 to $4 per prescription, with total cost sharing capped at 5% of household income.
Does the $35 insulin cap apply to Medicaid?
No, that is a Medicare provision. Medicaid enrollees generally pay less than $35 anyway. All three major manufacturers also now offer $35 monthly programmes for people without Medicaid.
My child was denied a CGM. What can I do?
Appeal citing EPSDT explicitly in writing. States must cover any medically necessary service for under-21s, including services not covered for adults, and blanket limits do not lawfully apply to children.
